Docoh
Loading...

XENE Xenon Pharmaceuticals

468 filings

Newest first
Filter options loading...
Top filers
Top filing types
Recent filing years
8-K
XENE Xenon Pharmaceuticals Inc
12 Jan 22
Xenon Pharmaceuticals Announces Collaboration with Neurocrine Biosciences Achieves $15.0 Million Regulatory Milestone
8:04am
4
XENE Xenon Pharmaceuticals Inc
17 Dec 21
Xenon Pharmaceuticals / MOHAMMAD AZAB ownership change
4:04pm
4
XENE Xenon Pharmaceuticals Inc
10 Dec 21
Xenon Pharmaceuticals / GARY PATOU ownership change
4:20pm
4
Seggern Christopher Von
7 Dec 21
Xenon Pharmaceuticals / Seggern Christopher Von ownership change
4:13pm
8-K
XENE Xenon Pharmaceuticals Inc
1 Dec 21
Entry into a Material Definitive Agreement
4:02pm
4
Pimstone Simon N.
16 Nov 21
Xenon Pharmaceuticals / SIMON N. PIMSTONE ownership change
8:40pm
10-Q
2021 Q3
XENE Xenon Pharmaceuticals Inc
10 Nov 21
Quarterly report
4:43pm
8-K
XENE Xenon Pharmaceuticals Inc
10 Nov 21
Xenon Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update
4:14pm
SC 13G
Point72 Asset Management, L.P.
28 Oct 21
Xenon Pharmaceuticals / Point72 Asset Management ownership change
5:24pm
424B5
XENE Xenon Pharmaceuticals Inc
6 Oct 21
Prospectus supplement for primary offering
5:05pm
8-K
XENE Xenon Pharmaceuticals Inc
6 Oct 21
Other Events
4:50pm
FWP
XENE Xenon Pharmaceuticals Inc
5 Oct 21
Free writing prospectus
4:34pm
424B5
XENE Xenon Pharmaceuticals Inc
4 Oct 21
Prospectus supplement for primary offering
5:27pm
S-3ASR
XENE Xenon Pharmaceuticals Inc
4 Oct 21
Automatic shelf registration
4:02pm
8-K
XENE Xenon Pharmaceuticals Inc
4 Oct 21
Xenon Pharmaceuticals Announces Positive Topline Results from Phase 2b ‘X-TOLE’ Clinical Trial of XEN1101 for the Treatment of Focal Epilepsy
7:03am
8-K
XENE Xenon Pharmaceuticals Inc
8 Sep 21
Xenon Pharmaceuticals Announces Collaboration with Neurocrine Biosciences Achieves $10.0 Million Regulatory Milestone
8:32am
4
Christopher John Kenney
25 Aug 21
Xenon Pharmaceuticals / CHRISTOPHER JOHN KENNEY ownership change
4:12pm
3
XENE Xenon Pharmaceuticals Inc
25 Aug 21
Xenon Pharmaceuticals / CHRISTOPHER JOHN KENNEY ownership change
4:05pm
8-K
XENE Xenon Pharmaceuticals Inc
23 Aug 21
Xenon Pharmaceuticals Strengthens Leadership Team with Appointment of Dr. Christopher Kenney as Chief Medical Officer
8:33am
10-Q
2021 Q2
XENE Xenon Pharmaceuticals Inc
11 Aug 21
Quarterly report
4:42pm